Natalizumab: FDA adverse event reports
181,031 FDA FAERS reports mention Natalizumab. 56,689 reports have a serious outcome flag.
Reported reactions
- Fatigue: 19,622 reports
- Multiple Sclerosis Relapse: 16,934 reports
- Headache: 10,006 reports
- Multiple Sclerosis: 9,787 reports
- Gait Disturbance: 9,502 reports
- Fall: 8,055 reports
- Asthenia: 8,012 reports
- Memory Impairment: 7,961 reports
- Malaise: 7,416 reports
- Drug Ineffective: 6,918 reports
- Urinary Tract Infection: 6,327 reports
- Pain: 5,986 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.